E-mail a Wiley Online Library Link

Frederik B. Thomsen, Mikkel Bandak, Maria F. Thomsen, Jakob Lauritsen, Ib J. Christensen and Gedske Daugaard Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older Cancer 120

Version of Record online: 24 SEP 2013 | DOI: 10.1002/cncr.28374

Compared with a younger control group, patients aged ≥40 years who have disseminated germ cell cancer and receive standard chemotherapy with bleomycin, etoposide, and cisplatin have increased cancer-specific mortality compared with a younger control group and decreased overall survival compared with the expected survival for the general population. This increased mortality is not caused by treatment toxicity or reduced doses of cisplatin/etoposide.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field